Literature DB >> 23061174

Personal characteristics and cognition in older African-Americans with hypertension.

Kay W Klymko1, Nancy T Artinian, Rosalind M Peters, Peter A Lichtenberg.   

Abstract

Hypertension disproportionately affects all African-Americans and lack of adequate blood pressure control could contribute to cognitive decline among older adult African-Americans. Cognitive difficulties might impair the self-management ability of these individuals, further limiting their blood pressure control. The purpose of this study, therefore, was to determine the personal characteristics that were associated with cognitive difficulties in order to identify older adults who needed environmental supports to enhance their self-management capabilities. A sample of 102 African-Americans from 60 to 89 years of age with diagnosed hypertension was recruited. Forty-nine percent (n = 50) of the sample had cognitive impairments that could hinder hypertension self-management. Depressive symptoms were also associated with a decrease in cognitive function (i.e., orientation and complex cognitive skills), as well as being negatively associated with social support. These findings support the need for nurses to assess personal characteristics in order to plan self-management strategies that help clients compensate for cognitive deficits.

Entities:  

Mesh:

Year:  2011        PMID: 23061174      PMCID: PMC3618909     

Source DB:  PubMed          Journal:  J Natl Black Nurses Assoc        ISSN: 0885-6028


  29 in total

Review 1.  National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence.

Authors:  A V Chobanian; M Hill
Journal:  Hypertension       Date:  2000-04       Impact factor: 10.190

2.  Effective screening for Alzheimer's disease among older African Americans.

Authors:  B T Mast; J Fitzgerald; J Steinberg; S E MacNeill; P A Lichtenberg
Journal:  Clin Neuropsychol       Date:  2001-05       Impact factor: 3.535

3.  Psychosocial characteristics after acute myocardial infarction: the ENRICHD pilot study. Enhancing Recovery in Coronary Heart Disease.

Authors:  C F Mendes de Leon; V Dilillo; S Czajkowski; J Norten; J Schaefer; D Catellier; J A Blumenthal
Journal:  J Cardiopulm Rehabil       Date:  2001 Nov-Dec       Impact factor: 2.081

4.  Hypertension improvement through healthy lifestyle modifications.

Authors:  Brenda D Rigsby
Journal:  ABNF J       Date:  2011

5.  The MacNeill-Lichtenberg Decision Tree: a unique method of triaging mental health problems in older medical rehabilitation patients.

Authors:  S E MacNeill; P A Lichtenberg
Journal:  Arch Phys Med Rehabil       Date:  2000-05       Impact factor: 3.966

6.  Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial.

Authors:  W M Vollmer; F M Sacks; J Ard; L J Appel; G A Bray; D G Simons-Morton; P R Conlin; L P Svetkey; T P Erlinger; T J Moore; N Karanja
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

7.  Hippocampal volume and incident dementia in geriatric depression.

Authors:  David C Steffens; Martha E Payne; Daniel L Greenberg; Christopher E Byrum; Kathleen A Welsh-Bohmer; H Ryan Wagner; James R MacFall
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

8.  Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials.

Authors:  G A Kelley; K S Kelley
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

9.  Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.

Authors:  Seamus P Whelton; Ashley Chin; Xue Xin; Jiang He
Journal:  Ann Intern Med       Date:  2002-04-02       Impact factor: 25.391

10.  Effects of six anti-hypertensive medications on cognitive performance.

Authors:  Matthew F Muldoon; Shari R Waldstein; Christopher M Ryan; John Richard Jennings; Joanna M Polefrone; Alvin P Shapiro; Stephen B Manuck
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.